317 related articles for article (PubMed ID: 29299091)
21. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
22. Renal oncocytoma displaying intense activity on 18F-FDG PET.
Blake MA; McKernan M; Setty B; Fischman AJ; Mueller PR
AJR Am J Roentgenol; 2006 Jan; 186(1):269-70. PubMed ID: 16357422
[No Abstract] [Full Text] [Related]
23. Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.
Sheikhbahaei S; Jones CS; Porter KK; Rowe SP; Gorin MA; Baras AS; Pierorazio PM; Ball MW; Higuchi T; Johnson PT; Solnes LB; Epstein JI; Allaf ME; Javadi MS
Clin Nucl Med; 2017 Apr; 42(4):e188-e193. PubMed ID: 28114223
[TBL] [Abstract][Full Text] [Related]
24. A Case of Renal Oncocytoma with Renal Venous Tumor Thrombus.
Kondo H; Okabe T; Okada Y; Hasebe T; Shirotake S; Oyama M; Nishimoto K
Keio J Med; 2019 Jun; 68(2):39-41. PubMed ID: 30473547
[TBL] [Abstract][Full Text] [Related]
25. F-18 FDG PET/CT imaging of submandibular gland oncocytoma.
Subramaniam RM; Durnick DK; Peller PJ
Clin Nucl Med; 2008 Jul; 33(7):472-4. PubMed ID: 18580232
[TBL] [Abstract][Full Text] [Related]
26. 18F-DCFPyL PET/CT in Oncocytoma.
Li J; Xu R; Kim CK; Bénard F; Kapoor A; Bauman G; Zukotynski KA
Clin Nucl Med; 2018 Dec; 43(12):921-924. PubMed ID: 30300203
[TBL] [Abstract][Full Text] [Related]
27. The role of molecular imaging in the characterization of renal masses.
Meyer AR; Allaf ME; Rowe SP; Gorin MA
Curr Opin Urol; 2018 Mar; 28(2):159-165. PubMed ID: 29319547
[TBL] [Abstract][Full Text] [Related]
28. Role of FDG PET/CT in imaging of renal lesions.
Kochhar R; Brown RK; Wong CO; Dunnick NR; Frey KA; Manoharan P
J Med Imaging Radiat Oncol; 2010 Aug; 54(4):347-57. PubMed ID: 20718915
[TBL] [Abstract][Full Text] [Related]
29. Preoperative evaluation of renal cell carcinoma by using 18F-FDG PET/CT.
Takahashi M; Kume H; Koyama K; Nakagawa T; Fujimura T; Morikawa T; Fukayama M; Homma Y; Ohtomo K; Momose T
Clin Nucl Med; 2015 Dec; 40(12):936-40. PubMed ID: 26164183
[TBL] [Abstract][Full Text] [Related]
30. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive hurthle cell tumor of the thyroid.
Wiesner W; Engel H; von Schulthess GK; Krestin GP; Bicik I
Eur Radiol; 1999; 9(5):975-8. PubMed ID: 10370003
[TBL] [Abstract][Full Text] [Related]
31. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
[TBL] [Abstract][Full Text] [Related]
32. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
[TBL] [Abstract][Full Text] [Related]
33. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Ong SC; Ng DC; Sundram FX
Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
[TBL] [Abstract][Full Text] [Related]
34. Adrenocortical oncocytoma displaying intense activity on 18F-FDG-PET: a case report and a literature review.
Kim DJ; Chung JJ; Ryu YH; Hong SW; Yu JS; Kim JH
Ann Nucl Med; 2008 Nov; 22(9):821-4. PubMed ID: 19039562
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic difficulties and value of partial surgery in multiple tumors of the kidney. Apropos of 4 cases].
De la Taille A; Houdelette P; Houlgatte A; Berlizot P; Lanfrey P; Atger M
J Urol (Paris); 1996; 102(4):139-43. PubMed ID: 9091562
[TBL] [Abstract][Full Text] [Related]
36. Remote Development of Tumor-to-Tumor Metastasis of Breast Adenocarcinoma in a Renal Oncocytoma.
Bitner DP; Clements MB; Cathro HP; Mithqal A; Schenkman NS
Urology; 2017 Sep; 107():e1-e2. PubMed ID: 28551171
[TBL] [Abstract][Full Text] [Related]
37. Incidence of thyroid carcinoma in fluorodeoxyglucose positron emission tomography-positive thyroid incidentalomas.
King DL; Stack BC; Spring PM; Walker R; Bodenner DL
Otolaryngol Head Neck Surg; 2007 Sep; 137(3):400-4. PubMed ID: 17765765
[TBL] [Abstract][Full Text] [Related]
38. Increased FDG Uptake on Juxtaglomerular Cell Tumor in the Left Kidney Mimicking Malignancy.
Jiang Y; Hou G; Zhu Z; Zang J; Cheng W
Clin Nucl Med; 2020 Mar; 45(3):252-254. PubMed ID: 31977483
[TBL] [Abstract][Full Text] [Related]
39. [Renal oncocytoma with synchronous contralateral renal cell carcinoma].
Nishikawa K; Fujikawa S; Soga N; Wakita T; Arima K; Yanagawa M; Kawamura J
Hinyokika Kiyo; 2002 Feb; 48(2):89-91. PubMed ID: 11968734
[TBL] [Abstract][Full Text] [Related]
40. [Bilateral multiple renal oncocytoma. Case report and review of the literature].
Villanueva Peña A; Roca Edreira A; De Diego Rodríguez E; Hernández Rodríguez R; Gutiérrez Baños JL; Aguilera Tubet C
Prog Urol; 2007 Sep; 17(5):997-9. PubMed ID: 17969806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
